Ventricular Assist Devices (VADs) provide long-and short-term support to chronically-ill heart disease patients; these devices are expected to match the remarkable functionality of the natural heart, which makes their design a very challenging task. Blood pumps, the principal component of the VADs, must operate over a wide range of flowrates and pressure heads, and minimize the damage to blood cells in the process. They should also be small to allow easy implantation in both children and adults.
Introduction
Computational Fluid Dynamics (CFD) has made impressive progress in the past decade and has evolved into a promising design tool for the development of biomedical devices. This article focuses on the evolution and current state of analysis of Ventricular Assist Devices (VADs) that support the circulatory system of patients suffering from Heart Failure (HF), which is the most common fatal disease in developed countries. Due to the permanent shortage of donor hearts available for transplantation, VADs are often the last hope for end-stage HF patients; these devices can now provide circulatory support for periods up to 2 years [99] . The blood pump is the key component of a VAD system, and its design has greatly benefited from CFD; however, the design of blood pumps still presents significant challenges.
The main function of a blood pump is to deliver adequate hydraulic performance while maintaining good hematological compatibility. Hydraulic performance implies the pump's ability to generate a desired flux at a given pressure head (resistance); hematological requirements arise because non-physiological flow conditions in a pump often lead to hemolysis (hemoglobin release from red blood cells, or RBCs) and thrombosis (clotting of blood). Hemolysis beyond a certain level and thrombosis are the two major life risk factors for patients who depend on a VAD. CFD is an excellent analysis tool to deliver detailed insight into the complex patterns of blood flow that determine hydraulic performance. Moreover, in combination with an adequate blood damage model, CFD allows quantitative prediction of hemolysis. It also supports the engineer in identifying recirculation areas and other regions with an increased probability for blood clotting.
This article reviews the research in hemodynamics and blood damage analysis. The presented numerical examples are based on the numerical approaches employed by the authors' research groups, and applied to the simulation of the GYRO centrifugal pump, under development at Baylor College of Medicine. Statistics pertaining to HF are discussed in Section 2. Section 3 describes existing types of VADs; the role of CFD in their design process is analyzed in Section 4. The rheology of blood and some constitutive models that endeavour to represent the complex flow behaviour of blood are described in Section 5. Section 6 reviews numerical flow analysis, where blood is considered as an idealized Newtonian fluid. The mathematical models for hemolysis are reviewed in Section 7. Section 8 describes the numerical solution for the flow of blood modelled as a viscoelastic Oldroyd-B fluid. Aspects of an automatic design optimization are described in Section 9. In Section 10, we conclude with some future directions for the developments in the field.
Heart Failure
HF is a clinical syndrome that implies dysfunction of the heart's ventricle and a limited cardiac performance. HF develops gradually as the heart muscle weakens and causes an imbalance in pump function, i.e., the heart fails to maintain adequate blood circulation. The term Congestive Heart Failure (CHF) is used if the reduced pumping ability of the heart leads to the build-up of fluid in the lungs and other body tissues.
By 2004, more than 20 million people suffered from HF worldwide, and 2 million new cases are diagnosed each year [117] . The number of people afflicted with HF is particularly high in the developed countries due to higher life expectancy and older population. Nutritional life-style including excessive consumption of high-fat food leads to hyperlipidemia, which constitutes a further risk factor for accelerated atherosclerosis (formation of plaque in the walls of the arteries leading to narrowing of blood vessels) and ultimately HF [119] . In the USA alone, 5 million cases of HF were reported in 2002 and 550,000 new cases are reported every year [17] . About 1% of all newborns are afflicted with a debilitating congenital heart defect [75] . On average 49% of men and 32% of women of age > 40 are at risk of developing HF [17] , and it is the most prominent cause of hospitalization for people aged > 65 [74] . Approximately 20% of the patients die in the first year after the diagnosis, and 70-80% have life spans shorter than 8 years. In 2003, 286,700 deaths in USA were caused by HF, representing one in every five deaths [17] .
Heart transplant remains the only permanent treatment for end-stage patients; however, only 2,500 donor hearts become available each year while 50,000 patients remain in waiting [51] . The waiting times for patients with an urgent need of heart transplant are normally longer than 2 years. Anually, care and treatment of HF patients costs the American Health Care System $29.6 billion [17] .
Ventricular Assist Devices
As evidenced by the statistics in Section 2, heart transplantation alone cannot suffice as a clinical solution for all HF patients; therefore, Total Artificial Hearts (TAHs) as well as VADs are being increasingly used to provide support to ailing heart and alleviate suffering. For brevity, this article focuses only on computational analysis of VADs; the modelling and simulation issues are basically the same as in TAHs, and distinction is blurring with new uses of paired VADs functioning as a TAH.
A VAD is defined as a temporary life-sustaining system which consists of a blood pump, a power supply and a control unit, and is used to support the blood circulation by decreasing the workload of the heart while maintaining adequate blood pressure [99] . However, these devices are now being envisaged as permanent clinical solutions.
In 1966, a VAD was successfully implanted into a patient for the first time. In 1982, a Jarvik-7 artificial heart was implanted in a patient who survived on it for almost 4 months [51] . Since 1990, as new technologies gradually allowed for more efficient heart pumps, several companies started the development of VADs. In 1994, the U.S. Food and Drug Administration (FDA) approved left ventricular assist devices (LVADs), i.e., VADs that specifically support the work of the left ventricle, as a bridge to transplant. The 2001 Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) study demonstrated that more than twice the number of patients with end-stage HF survived during a one-year period compared to patients receiving merely medical therapy [116] . In 2002, the FDA approved the use of LVADs for longterm therapy in severe HF patients, who cannot be candidates for heart transplants [89] .
Anatomically, the VADs are implanted either internally in the abdomen (DeBakey, Heartmate, Novacor, etc.) or in the pericardial space (Heartware HVAD, etc.), while in other cases, such as the pulsatile Thoratec VAD, the pump is placed extracorporeally. Takatani [130] listed more than 30 different heart pumps that have been in clinical use or under development until 2001. The cost of a single VAD is typically over 50,000 US dollars [7] ; however, these devices have the potential to bring overall financial relief to the national health systems. Table 1 lists the different configurations in which VADs are used and their respective functions. Depending on whether VADs are connected to the left, right or both ventricles, they are referred to as left-(LVAD), right-(RVAD) or bi-ventricular assist device (BIVAD), respectively. These devices can also be used in a TAH configuration in which the diseased heart is replaced completely; however, VADs can be removed if the patient's heart recovers. The optimal operating conditions depend on physiological properties of the patient's cardiovascular system. An approach to quantify and parameterize the range of operating conditions is given in [146] .
Current Applications
Based on suggested period of usage, the VADs can be classified into 2-day, 2-week, 6-month, 2-year and permanent models [98, 99] . Table 2 shows current blood pump models, their applications and associated requirements.
Commercially available VADs exist for short-term support, e.g., during critical surgeries, Extracorporeal Membrane Oxygenation (ECMO), Percutaneous Cardiopulmonary Support (PCPS) to medium and long-term bridging support. A bridge to therapy and recovery is used to unload partially or completely the diseased heart. Patient studies have shown that by a prolonged support of the heart's pumping function after several months up to 1 year, apparent signs of the natural heart's recovery were diagnosed [98, 99] . After 2 years, the recovery due to ventricular unloading cannot be improved beyond the optimum [72] . The bridge to transplant requires a durability that matches the waiting time for a donor heart which is often more than 2 years. Permanently implantable blood pumps are currently in development. Table 2 . Blood pump models, their application and associated requirements; "X" indicates mandatory feature, "(X)" indicates preferable feature. 
Design Requirements
The development of a blood pump has to satisfy several general requirements such as atraumatic behaviour, affordability, control feasibility, reliability, good implantability, and applicability for different physiological demands varying from patient to patient [143] . Apart from such general requirements, different applications require different pump designs, each of which poses particular technical challenges as listed in Table 2 . Often, design objectives oppose each other and one design criterion is optimized to the detriment of another one. For long-term bridging models, integration of the energy supply and control unit into the implanted device avoids inflammation of the tissue, a frequent complication occuring to patients using a VAD with extracorporeal connection.
As a blood-pumping device, the VAD has to be designed to provide:
• adequate hydraulic performance assisting the physiological pumping, and • good hemocompatibility which implies minimal blood damage.
Blood damage can occur either by thrombosis or hemolysis. Antithrombogenicity and minimization of hemolysis resulting from high shear stresses [97] are the most important hematological design features. The two primary damage mechanisms are explained briefly below. Thrombosis: Thrombosis is the formation of a clot or thrombus and is initiated by the body's hemostatic mechanisms to prevent unnecessary bleeding. The processes that lead to clotting are complex and have been described in Refs. [48, 61, 144] and the references therein. The three primary factors can be summarized under the term Virchow's triad [139] : alterations in blood flow, abnormalities of the vascular wall, and alterations in the constitution of blood. Therefore, inside VADs, regions of high shear stress, recirculation or stagnation and blood contacting surfaces with low hemocompatibility must be avoided. When the thrombus formation mechanism has been triggered by such nonphysiological causes, it can lead to a pathologically-high degree of clotting. If a thrombus forms on a surface of the VAD, it may compromise its function, and if it circulates as a free thrombus in the blood stream, it can occlude blood vessels in vital organs. These thromboembolic incidents count among the primary causes of death for patients with ventricular assist support. Hemolysis: Hemolysis refers to premature RBC damage and its indicator is the release of hemoglobin from the erythrocyte into the plasma. In artificial organs, mechanical damage resulting from high shear stress levels and exposure times to these stress levels is the main cause of hemoglobin release; contributions from other effects such as osmosis, chemical and thermal processes are negligible [11] . Modern atraumatic blood pump design can avoid catastrophic rupture of RBCs; however, sublethal RBC damage needs to be reduced for all middle and long-term blood pump models. A more detailed explanation of hemolysis and the associated physical mechanisms is given in Section 5.3. Minor hemolysis can raise the level of hemoglobin in the blood to deteriorate the patient's condition. Moreover, a large concentration of plasma free hemoglobin, which must be filtered by the kidneys, can cause kidney dysfunction [102] and multiple organ failure.
Classification of VADs
From a technological point of view, VADs can be classified into 3 generations [101, 102] ; the charachteristics, advantages and disadvantages of each of them are summarized in Table 3 .
First-generation blood pumps are positive-displacement or pulsatile pumps. In the 1980s, in vivo studies [92, 131, 158] gave evidence that animals could survive for a long period of time in an entirely depulsed state, proving that pulsatile blood flow does not represent a necessary physiological condition. Until today, the debate continues among investigators on whether pulsatile mechanical support provides any substantial benefit to the patient by reproducing the natural heart beat and blood flow. Ref. [137] lists different aspects of pulsatile compared to non-pulsatile perfusion.
Second-generation blood pumps are non-pulsatile pumps. They are characterized by the use of a spinning impeller providing a continuous blood flow. Typically, secondgeneration VADs use contact bearings and/or seals, where the bearings are immersed in the blood stream or separated from the stream by seals.
The transition from second-to third-generation rotary blood pumps is characterized by magnetic bearings allowing the impeller to be suspended. Ref. [143] and references therein argue that the third-generation systems are at present the leading technology in the development of mechanical circulatory support.
Rotary Blood Pumps
Rotary pumps can be classified into two categories-centrifugal and axial. The centrifugal pumps, e.g., GYRO pump, shown in Figure 1 (a), can produce higher pressures at lower rotational speeds, whereas axial pumps, e.g., MicroMed DeBakey pump, shown in Figure 1(b) , operate at higher speeds to build up the pressure head required for the desired flow rate [128] . Higher speeds may lead to high shear stresses and thus higher probability of blood damage. For this reason, centrifugal pumps provide "gentler" flow conditions; conversely, the shorter exposure times in axial pumps are expected to play a positive role. Advantageous applications of centrifugal pumps for VADs and other medical blood flow devices are described by Curtis [47] . Axial pumps are smaller and consume less power; therefore, they can be implanted more easily and are more suited for pediatric use. A description of nine of the most recent and established axial blood pump designs can be found in Ref. [125] . The particular pump design that is used in some of the numerical examples later in this article is described below.
GYRO Centrifugal Pump:
The GYRO centrifugal pump has been under development at the Baylor College of Medicine, Houston, Texas [96, 97, 157] . This pump has an impeller with six primary (top) and two secondary (bottom) vanes rotating inside a cylindrical pump housing. The bottom vanes are designed to create a secondary flow that increases bottom bearing washout. A double-pivot bearing system is used in order to obtain a sealless pump casing. The pump has a diameter of 6.5 cm and a priming volume of 25 ml. The inflow cannula is attached to the upper housing surface and the outflow cannula is attached horizontally to the pump casing, both with a diameter of 0.8 cm. The inflow is positioned eccentrically in the vicinity of the top bearing in order to generate additional flow around the top shaft with the purpose of further reducing stagnant regions. Under typical operating conditions, the GYRO pump produces a flow of 5 L/min against 100 mm Hg pressure at a rotor speed of 2,000 rpm. Hydraulic testing is mainly performed using Particle Image Velocimetry (PIV) [18, 49] and Particle Tracking Velocimetry (PTV) [132, 141, 149, 150] , which provide the velocity and stress fields. These techniques can be employed to confirm design expectations and to identify zones with a high potential for causing hemolysis or thrombus formation. One limitation of flow visualization lies in its low resolution of critical areas, leading to lowfidelity predictions of flow characteristics in zones of particular interest. Generally, this difficulty is dealt with by performing the velocimetry in enlarged models, with associated scaling issues and problems. Another limitation is the need to perform the measurements in transparent models [18] . Finally, state-of-the-art visualization methods do not allow to employ blood as a working fluid during testing [132] . A promissing future approach for measuring velocities of blood particles in blood pumps is the NMR method [33] . The method allows the use of blood as the test fluid and it has been applied to investigate blood flow in capillaries and tubes [69] .
In vitro hematologic testing uses mock circulatory systems [83] which require large amounts of blood. Human blood is not easily available and no equivalent artificial fluid has been produced so far; further restrictions on blood use for experiments are cited in [64] . As an alternative to human blood for mock up tests, many experimental studies have used animal blood, which compared to human blood displays different behaviour in terms of rheological properties and mechanical fragility. All these factors exacerbate the difficulties of obtaining a reproducible and quantitatively adequate estimation of blood trauma based on in vitro testing.
In vivo studies are only able to give information about global design features, as the device is fully implanted in the living animal's circulatory system.
Numerical Design Tools
CFD made its methodical appearance in the field of heart pump development in the 1990s. CFD can be employed in the early stages of the design process as well as in later stages of optimization. Nowadays, the design of medical devices involving blood flow, such as blood pumps, oxygenators, and artificial heart valves, increasingly benefits from CFD modelling.
CFD represents a convenient and efficient tool for the analysis of hydraulic efficiency and flow patterns in the pump. It provides information such as the location and size of stagnation zones, local shear stress levels and exposure times of RBCs to such stresses; these parameters can then be correlated to the extent of hemolysis and thrombus formation. In the past decade, progress in blood modelling has made CFD a powerful tool for the estimation of flow-induced blood damage. Based on hemolysis predictions, it is possible to perform pump optimization according to blood-specific requirements.
The generally demanding computational resources for CFD studies are compensated by considerable advantages:
• CFD is time-and cost-effective because prototype building and experiments can be minimized.
• CFD can pinpoint the exact flow features inside the device.
• Modifications of the device model can be easily implemented.
Human Blood

Blood as a Complex and Fragile Fluid
Blood, which exhibits a highly complex, flow-dependent physical, and chemical constitution, is composed of plasma, a Newtonian liquid of viscosity 1 mPa · s, RBCs, White Blood Cells (WBCs) and platelets. Approximately 90% of the plasma is water, and the rest is composed of dissolved substances, primarily proteins, e.g., albumin, globulin and fibrinogen. The volume percentage of plasma typically accounts for 55% and the remaining 45% is almost entirely composed of RBCs. Only up to 1% of the total cell mass in blood is formed by platelets and WBCs. Platelets are 2 − 4 µm disk-shaped particles that are involved in the cellular mechanisms that initiate the wound healing cascade through the formation of blood clots. The WBCs are responsible for the body's defense against infectious disease and foreign materials as part of the immune system. RBCs contain hemoglobin which has the function of distributing oxygen to the tissues and organs. Non-physiological conditions, in particular high shear stresses over a prolonged time, can cause damage to the RBCs. Characteristic shear stresses acting on blood in the human vessels as opposed to artificial organs are listed in [84] . These stresses lie within a range of 0.1-1 Pa in healthy human veins and 1-20 Pa in healthy human arteries, but this value can increase up to 50 Pa in narrowed arteries caused by stenotic lesions. In artificial blood pumps, typical values are found in a range of 1-1,000 Pa. Experimental evidence shows that in the practical range of exposure times (10 µs to 100 ms) RBCs are less resistant to shear than platelets [70] . The total characteristic residence time of a RBC in a VAD is on the order of 500 ms.
Red Blood Cells
RBCs are well-adapted to resist shear stresses encountered under physiological conditions when blood is pumped through the network of narrow capillaries. When no external forces act on the membrane, a RBC takes the shape of an axisymmetric, biconcave, disklike body. Its dimensions are determined by the elastic properties of the membrane, its surface area and enclosed volume. RBCs measure typically 6 − 8 µm in diameter and have a thickness of 2.2 µm [29] . Their average volume and surface area are 92 µm 3 and 140 µm 2 , respectively [59] . Because of its biconcave shape, a RBC has 40% excess surface area compared to a sphere of the same volume, enabling the cell to undergo deformations that preserve both volume and surface area. From a mechanical point of view the RBC can be described as an incompletely inflated bag (the plasma membrane) filled with a viscous fluid (the cytoplasm) [142] . The cytoplasm behaves like a Newtonian liquid with a viscosity of approximately 6 mPa · s (cP); it is mostly filled with the glycoprotein hemoglobin which is equally efficient at binding and releasing oxygen.
Mechanisms of Hemolysis
The main source of hemolysis in blood pumps is the sublethal damage of the RBCs due to leaking of hemoglobin rather than catastrophic damage due to rupturing at shear rates above 42,000 s −1 [86] . Premature hemoglobin release shortens the RBC's normal life span which for a healthy person is 120 days [29] . Sublethal damage does not occur immediately under stress but requires time for the RBCs to undergo deformation. The RBCs at rest aggregate into coin-stack-shaped structures called rouleaux, which disperse as shear stress increases. The dispersed RBCs preserve their biconcave shape and tumble in a flow with shear stress below ∼ 0.1 Pa [120] . As shear increases, the tumbling slows and the cells align with the flow at ∼ 0.2 Pa. At shear stress greater than 1 Pa, they deform progressively into prolate ellipsoids with their long axes aligned parallel to the flow direction. This deformation is accompanied by an orientation of the cell in the shear planes and a rotational motion of the cell membrane around its contents [142] . Due to its resemblance with the rotation of the tread of a tank around its wheels, this phenomenon is referred to as tank-treading. If the cell is deformed by shear stresses that do not exceed a critical value and exposure time [56] , it recovers its natural shape when the forces causing the deformation are removed. Even peak stress values of 1,000 Pa were found to produce only insignificant hemolysis if the exposure time did not exceed a few milliseconds [29] . The membrane can support an estimated areal strain of 6% before rupturing and has an average relaxation time depending on the membrane viscosity and elasticity which was experimentally determined as 200 ms [71] . Above 150 Pa the membrane reaches its areal strain limit, microscopic pores in the membrane open and allow hemoglobin to leak into the blood stream. Extensive hemolysis occurs as a function of the stress and exposure time [86] . The cell membrane is to a certain extent permeable to water, oxygen, carbon dioxide and other small molecules but impermeable to hemoglobin [29] . For that reason the release of hemoglobin ∆Hb into the plasma has been chosen as the indicator for hemolysis.
In order to assess quantitatively the amount of hemolysis from blood within a mock test loop, different clinical indices have been introduced; the Normalized Index of Hemolysis (N IH) has become the ASTM standard [4] . The N IH is related to the proportion of ∆Hb and the total amount of hemoglobin Hb as
where Hct denotes the hematocrit (%), i.e., the proportion of blood volume occupied by RBCs (45 % for a healthy person and 37 % for normal bovine blood), and κ is the hemoglobin content of the blood (150 g/L for a healthy person).
Rheological Modelling
In large vessels with a diameter more than two orders of magnitude greater than the size of an RBC, blood can be modelled as a homogeneous fluid [34] . At the macroscale, there exist different models with different degrees of accuracy in capturing the rheological behaviour of blood. In CFD analysis of flow quantities inside VADs blood is usually considered as a Newtonian fluid although it is known to display non-Newtonian properties [53, 136] . Blood's viscosity is shear-thinning because of the disaggregation of the rouleaux and the orienting of individual RBCs [40, 41] . Blood also shows nonlinear viscoelastic behaviour resulting from the elastic membranes of its constituents. Finally blood is thixotropic; its viscosity can vary with time at constant low shear mainly due to rouleau aggregation and disaggregation. The viscosity of blood depends on the blood sample hematocrit and temperature but in general the qualitative behaviour of any blood sample is the same [54] . In experimental studies [39] it has been shown that at high shear rates (above 100 s −1 ), the viscosity of human blood with 45 % hematocrit reaches a constant value of 3.5 -4.0 mPa · s, thus justifying somewhat the choice of a Newtonian model for VADs.
Generalized Newtonian constitutive models, which consider shear-thinning effects, have been used to model blood, e.g., the Carreau-Yasuda model [12, 63] and the modified Cross model [85] . However, complex constitutive models for blood have also been introduced, where blood is modelled as a viscoelastic fluid [6, 103, 154, 156] . In particular, constitutive equations from the Oldroyd-B class have the best potential for capturing with reasonable accuracy the rheological behaviour of blood [154, 156] while, at the same time, being tractable in complex 2-D and 3-D flows. These constitutive equations belong to the more general conformation tensor class, where the microstructure of the fluid is captured by one or more internal variables [27, 66, 68, 107, 108] . In the Oldroyd-B model, blood is assumed to consist of macromolecules (RBCs) in a Newtonian solvent (the plasma) and is accordingly modelled as a polymeric solution where the elastic properties of a given flow are characterized by the dimensionless Weissenberg number Wi = λγ, with λ being the relaxation time of the fluid, andγ the shear rate of the flow. Equations of the Oldroyd-B type-i.e., for viscoelastic flows-have been used recently in numerical studies of blood flow [85, 109] . The effective solution of complex flows of Oldroyd-type fluids has been an important research problem since the late 1970s [45] ; recent reviews can be found in the works of Baaijens [19] , Keunings [81] , and Owens and Phillips [104] . A very recent review on currently used models for blood can be found in [103] . An experimental comparative study of different constitutive models for blood was conducted by Zhang [162] . Owens [103] proposes a new microstructure-based constitutive model for blood built on polymer network theory with the objective of describing rouleau aggregation and disaggregation as well as blood's shear-thinning, viscoelastic and thixotropic properties.
In the finite element context, the solution of viscoelastic flows relies on unequal-order finite element methods. Unequal-order finite element methods are at a disadvantage compared to equal-order approach due to higher levels of costly indirect memory addressing on modern cache-based computer architectures.
The fact that today Newtonian modelling is generally used by the scientific community for VADs stems from its relatively good accuracy for high-shear applications and from the high computational effort involved in solving complex constitutive models for blood.
We will be modelling blood as a Newtonian fluid for the blood pump application in Sections 6 and 7. For the graft application mentioned in Section 9 where non-Newtonian effects become important we used a shear-thinning modified Cross model and in Section 8 we describe a numerical method to solve viscoelastic flow for an Oldroyd-B fluid. Table 4 summarizes previous works focusing on or including CFD-based hydraulic efficiency investigations of rotary blood pumps. Among the first numerical simulations to predict the hydraulic performance and shear stresses inside a blood pump were the studies performed by Papantonis and Croba [105, 106] and by Pinotti and Rosa [110, 111] , who used a simplified pump model assuming an assembly of parallel co-rotating disks.
A broad variety of different blood pump applications have been analysed by the research group from the Universities of Utah and Virginia, ranging from centrifugal [3, 8, 46, 127] and axial [138] pumps for adults to centrifugal [135] and axial [134] pumps for pediatric use.
Design improvements are generally made by approaches based on the designer's intuition. The benefit of CFD in this context is that it offers the potential to guide the VAD designers towards improvements of single pump components [15, 28, 37, 46, 115] .
Antaki et al. [9, 36, 145] have stressed the advantages of coupling between numerical simulation and mathematical optimization techniques with the goal of an optimal design, which will be reviewed in Section 9.
The complex blood pump geometries have led to the common use of finite difference methods based on overset grids, or more frequently, finite element or volume methods based on unstructured grids. In order to solve the Navier-Stokes equations, adequate analysis tools are required where the numerical solvers are expected to be robust and efficient. Table 5 shows which discretization methods are used in combination with the chosen solvers. Most of the research groups listed in Table 4 the commercially-available numerical solver CFX-TASCflow (before 1998 also known by the names of CFDS-Flow3D and CFX-4), which involves a hybrid finite volume/finite element methodology in the sense that control volumes are constructed around nodes and finite elements describe the solution variation within each element. Further commercial flow solvers for blood pump analysis that have been used in some cases are FLUENT and STAR-CD. Other research teams used their own implementations of published or self-developed algorithms, e.g., the Ohio University group listed in Table 4 used a finite difference scheme developed by Nakamura [93] based on the SMAC algorithm [5] . The authors of this review have used an in-house finite element-based code XNS in order to solve the Navier-Stokes equations of incompressible flow, employing an iterative solver GMRES [118] . A decision tree and details on the authors' choice of the numerical method can be found in [22] .
Results from the works cited in Table 4 show largely satisfactory agreement between hydraulic performance prediction and experimental results.
Equations Governing Blood Flow
The isothermal, incompressible flow of a fluid in bounded domain Ω t and boundary Γ t is given by conservation of mass and momentum equations:
1)
where ρ is the fluid density (1058 kg/m 3 ), u is the fluid velocity, u ,t its time derivative, p is pressure, and f are body forces per unit mass, e.g., gravity. For a Newtonian fluid, the stress tensor σ is given as:
where I is the identity tensor, T is the viscous stress, µ is the viscosity (3.5 mPa · s),
is the rate-of-strain tensor, and ∇u is the velocity gradient. The Dirichlet and Neumann-type boundary conditions are imposed on complementary subsets (Γ t ) g and (Γ t ) h of the boundary Γ t as:
Galerkin/Least-Squares (GLS) Formulation
Finite element methods try to find an approximate solution of partial differential equations by solving a discretized form of the governing equations (6.1-6.2). Since the early 1970s the Galerkin finite element method has been the prevailing method used in structural mechanics. However, in the context of fluid flow simulations, the Galerkin method exhibits stability problems, e.g., negative numerical diffusion which may result in spurious node-to-node oscillations in velocity for advection-dominated flow. Upwinding schemes [76] , Streamline-Upwind/Petrov-Galerkin (SUPG) methods [35] , and Pressure Stabilized/PetrovGalerkin (PSPG) methods [133] were developed to overcome these shortcomings of the Galerkin method. The GLS method [77] used here combines the SUPG and PSPG stabilizations in one conceptually simple term and has proven to have good stabilization, consistency, and convergence characteristics [57, 58, 77] . In space-time methods, the stabilized finite element formulation of the governing equations is written over the space-time domain of the problem. The finite element function spaces are constructed by partitioning the time interval (0, T ) into subintervals I n = (t n , t n+1 ), where t n and t n+1 are arranged in a sequence of time levels 0 = t 0 < t 1 < · · · < t N = T . Denoting Ω n = Ω tn and Γ n = Γ tn , the space-time slab Q n is defined as the domain enclosed by the surfaces Ω n , Ω n+1 , and P n , with P n being the surface formed by the boundary Γ t as t sweeps through I n . Analogous to Γ t , surface P n is decomposed into (P n ) g and (P n ) h with regard to the applied boundary condition (Dirichlet or Neumann). Appropriate finite element interpolation function spaces for the velocity and pressure are then defined for space-time time slab n-(S h u ) n and (S h p ) n -as well as corresponding weighting function spaces (V h u ) n and (V h p ) n . These spaces are defined as:
The stabilized space-time GLS formulation can be thus stated as: 9) where (·, ·) are suitable scalar or vector function inner products over domain and (u h ) ± n = lim ε→0 u(t n ± ε), and τ mom is the stabilization parameter-see [26] for details. The motion of the computational domain boundaries is accomodated by a deforming boundary-fitted mesh. The applied Shear-Slip Mesh Update Method (SSMUM) [23] is a method that allows the elements in a thin zone of the mesh to undergo "shear" deformation followed by limited remeshing that accommodates the desired displacement of one part of the domain with respect to another.
Experimental and Numerical Analysis Results
The computational domain and a typical finite element mesh for the GYRO Pump are shown in Figure 2 . The inflow boundary Γ in and outflow boundary Γ out form the Neu- mann portion of the boundary ((Γ t ) h in Section 6.3) of the boundary; the boundary conditions at the remaining surfaces are of Dirichlet type ((Γ t ) g in Section 6.3). Experimental data is generated using a mock loop as described in [25] . Glycerol and blood are employed as test fluids and the rotational speeds of the impeller used are ω = 1800, 2000, and 2200 rpm. In the computations, appropriate pressure head can be applied between Γ in and Γ out . The gradual ramp-up of that pressure head leads from a strongly transient to a quasi-stationary condition of the flow field. For ω = 2200 rpm, the flux histories shown in Figure 3 stabilize after 6-12 revolutions of the impeller, i.e., they achieve a near-sinusoidal profile with constant average and amplitude. The simulations were performed for ∆p = 100, 110, 120 and 125 mm Hg with 800, 800, 1200 and 1000 time steps, respectively [25] . Flow reversal was observed at ∆p = 130 mm Hg.
The overall hydraulic performance at ω = 1800, 2000, and 2200 rpm is presented in Figure 4 . The finite range in numerical flux data is due to the low-amplitude periodic All computations were performed on a Linux PC cluster, with Myrinet interconnect, on partitions ranging from 32 to 72 CPUs, and requiring 4-8 hours to obtain a quasi-steady flux at each flow condition.
Numerical Analysis of Blood Damage
Blood Damage Modelling
In spite of the intense research on blood damage modelling, there is currently no consensus on suitable models that relate fluid dynamics information, such as stress and shear rate, to clinical properties, such as the N IH.
Correlations for blood damage in artificial organs were established under the assumption of experimentally feasible conditions, which implied hemolysis under steady shear at short time intervals. Assuming that blood damage depends solely on shear stress and exposure time, several researchers have used a mathematical power-law model [65] to formulate hemoglobin release based on experimental data:
where ∆Hb Hb is the ratio of hemoglobin in the plasma to the total hemoglobin, τ is the scalar measure of the shear stress acting on the blood in Pa, and ∆t is the time duration of blood exposure to the shear stress τ in seconds. Gu and Smith [67] used a benchmark approach for an evaluation of different existing models presented by Giersiepen et al. [62] , Heuser and Opitz [73] , and Grigioni et al. [65] to evaluate the blood damage prediction accuracy of such models compared to experimental data. For hematological CFD-design of VADs, the most commonly adopted model considering steady-shear hemolysis experiments, is the one established by Giersiepen et al. [62] who derived the constants C, a and b from an empirical study in a cylindrical Couette system undertaken by Wurzinger et al. [147] . The following correlation was found:
Further studies in a modified Couette system including measurements for time-varying shear stress were performed by Klaus [82] , who uses an improved sealing system to exclude effects of temperature-induced hemolysis. Different authors have applied comparative stress theory to compute the scalar measure of τ in equation (7.1) from the second invariant of the deviatoric stress tensor:
In the following, this method of computing hemolysis will be referred to as stress-based method; it assumes that the RBC's response to load is immediate and independent of its load history. Bludszuweit [31] expressed the scalar shear stress value based on the von Mises criterion [79] which is calculated from the six components of the stress tensor:
Since then, this approach has been further elaborated to include some aspects of stress threshold and aging, as well as calibration for a specific device [15, 64, 155] . In contrast to the stress-based method, the authors' group presented a strain-based approach which will be described in Section 7.3.
Evaluation of Hemolysis Simulations
Equation (7.4) was introduced to assign scalar stress values to pathlines, where each of them represents a particle's path through the blood pump chamber. Based on this approach, Bludszuweit [32] described the methodology on how CFD can be used for hemolysis predictions in artificial organs and calculated overall damage as the sum of the partial influences of the loading function assuming constant and cyclic load functions to reflect RBCs' damage behaviour or resistance. In Refs. [30] [31] [32] , the stress-loading time functions for individual particles are determined for the Aries Medical Isoflow centrifugal blood pump and other types of artificial organs.
Between 1995 and 2001 other researchers began to use CFD in order to find a good hematological design for centrifugal blood pumps [88, 159] , axial blood pumps [11] or simplified blood pump models [111, 153] by relating local flow conditions to hemolysis. In those studies, hemolysis was discussed but blood damage was not quantified. In absence of quantitative hemolysis results, some authors interpreted peak stresses as threshhold levels for the occurence of hemolysis [159] .
By comparison to experimental data, it was found that equation (7. 2) tends to overestimate the actual blood damage in artificial organs. To cite some examples, De Wachter and Verdonck [50] found the computed hemolysis values for cannulae to lie in a range between 2 to 8 times the measured values, Goubergrits and Affeld [64] found a computed overestimation factor of 25 for a standard Björk-Shiley valve and Yano et al. [152] found a factor of 30 for the case of an axial blood pump; in all these cases, a stressbased approach was used. Grigioni et al. [65] draw attention to the inherent limitations of hemolysis estimations based on power-laws such as the one proposed by Giersiepen et al. [62] , and highlight the effect of a time-varying loading acting on RBCs, showing the need for a reassessment of the power-law model; or more precisely, the interpretation of the stress measure used in that model.
More recently, quantitative hematological CFD results based on a stress-based model and considering blood as a Newtonian fluid have been published for rotary blood pump designs [15, 16, 37, 90, 124, 127, 161] and for pulsatile blood pumps [100] . These authors used either Giersiepen's power-law equation (7.2) or Bludszuweit's stress model equation (7.4), or both. For the above mentioned rotary blood pump simulations, TASCflow was typically chosen as the solver and a Lagrangian particle tracking method was applied to add up the hemoglobin leakages along streamlines. Some novel approaches and insights regarding hemolysis predictions have been introduced: Comparative studies: Song et al. [124, 127] , Mitoh et al. [90] and Zhang et al. [161] reported good agreement of CFD blood damage predictions with experimental hemolysis data, thus demonstrating that CFD is a viable approach to analyze blood behaviour in a VAD. Choice of best design alternative: Arvand et al. [15] and Chan et al. [37] undertook their studies with the objective of finding the best hematological design for individual blood pump components from a predetermined set of different design options by comparing the computed blood damage rates for the competing design candidates. Semi-empirical pump-specific hemolysis model: Arvand et al. [16] set the estimated hemolysis index equal to the measured index and determined the constants of the power-law by regression analysis in order to receive the best fit. This results in an optimized hemolysis model, albeit restricted to a single pump configuration. Shape optimization: Wu et al. [145] proposed a parameterized geometry model of the blood pump and demonstrated an automatical optimization design approach; this topic is further discussed in Section 9. Influence of turbulence: Some researchers have stressed the important role of turbulence. Kameneva et al. [80] performed experiments in combination with CFD studies and found significantly varying hemolysis values at constant shear stress values for turbulent compared to laminar flow. In a comparative study between PIV and CFD-based analysis, Song et al. [126] found that the accuracy of flow predictions depends on the applied turbulence model, especially in near-wall regions. Influence of device orientation: Yuri et al. [160] found that the implantation position and orientation of the blood pump in the patient can have an influence on hemolysis. This is especially the case for the GYRO pump where implantation orientation affects the location of the magnetically levitated impeller.
Modelling of RBC Strain
As an alternative to stress-based models our research team has recently proposed a more fundamental approach [13] that takes into account the time-dependent history of RBC deformation, which may not correspond to the instantaneous shear stress levels in the surrounding fluid. This approach requires a mathematical representation of the RBC geometry.
In the scientific literature models of RBC deformation can be found in works focusing on microscale blood flow where RBCs are usually modelled as capsules [148] . A capsule is a particle with an elastic membrane enclosing a fluid. A description of the modelling and simulation of capsules can be found in [112, 114] . Applications of this approach to RBCs include simulation of simple shear flow [55, 113] , capillary flow [122] and rouleau aggregation [20] . It was observed that RBCs in shear flow behave as liquid droplets [60, 120] . In droplets, as opposed to capsules, the interfacial forces arise from surface tension. Microcapsules and biological cells such as RBCs represent an intermediate case between elastic solid particles and liquid droplets, behaving rather as a solid-like body in the low shear regime and attaining a steady-state orientation with a tank-treading motion of the membrane only at high shear rates [21, 123] .
Therefore in blood pumps where shear forces are typically high, our research group uses the simplified model of RBCs as neutrally-buoyant droplets. Other authors have also used a droplet analogy to simulate RBC flow behaviour in small and intermediate vessels [43, 44, 121] .
In our model the RBC shape is described by an evolution equation that incorporates specific characteristics of RBCs including shape recovery in the absence of shear and tank-treading motion. The RBC shape is simply described by a symmetric positivedefinite morphology tensor, which is subject to deformations due to forces exerted by the surrounding liquid. These forces compete with the interfacial tension, which tends to reduce the elongation of the ellipsoid, which can be modelled as spherical-shape restoration force (at high shear). A frame-invariant droplet deformation equation was proposed by Maffetone and Minale [87] , which accounts for non-affine droplet deformation, and extended by Arora et al. [13] to represent tank-treading:
where B is the morphology tensor, W = −3 are uniquely determined by RBC behaviour in steady shear flow. The orthonormal matrix Ω defines the rate of rotation of a reference frame attached to the eigenvectors of B, leading to E = E, and W = W −Ω. At any instant, the flow field is simulated and the morphology tensor evolution is tracked along pathlines through the pump. In this way, equation (7.5 ) yields information about the deformation, or strain, of the RBC at each point in the flow field. Because RBCs experiencing varying shear stresses require time to change their shape, the calculated strain acting on the blood cell does not lead to an instantaneous deformation as in the way predicted by steadyshear experiments. Therefore, the computed deformation of the RBC is correlated to a hypothetical shear that would lead to such deformation under steady conditions. Based on these shear values, the hemolysis rate can be computed using the experimental correlation given by the equation (7.2) . Next, the hemolysis rate is integrated along each pathline to calculate blood damage for individual RBCs, and by taking the average over a sufficientlyhigh number of pathlines, it is possible to calculate the hemoglobin release in the blood pump; this approach is referred to as the strain-based model [13] . Figure 5 schematically shows the difference between the stress-and strain-based modelling approaches.
Viscoelastic Modelling of Blood
The authors have been developing Galerkin Least Squares-type (GLS) finite element methods for solving the flow of viscoelastic fluids [22, 24, 42] ; the most recent version is the GLS4 method [42] , where the equations of the flow are converted into a set of firstorder partial differential equations, and the four flow field variables (velocity, pressure, velocity gradient, and elastic stress) are represented explicitly by basis functions-hence the name GLS4. This method is outlined below as an example of the mathematical complexity needed to handle viscoelastic flow equations. Adapted from [14] . Copyright Blackwell Publishing. Reprinted with permission.
The GLS4 method is attractive for large-scale computations, e.g., flow in a complicated three-dimensional blood pump. One characteristic of the GLS4 method is the use of lowand equal-order interpolation functions for all variables, which makes the method efficient and easy to implement on distributed-memory clusters.
In addition to the conservation of momentum and mass equations (6.1)-(6.2), the traceless velocity gradient and the transport of conformation are considered; the traceless velocity gradient L is defined as:
where tr denotes trace, while the conformation tensor M for the Oldroyd-B model obeys the evolution equation:
where the non-dimensional Weissenberg number Wi represents the product of the relaxation time and the shear rate of the flow.
Equation (6.3), for the Oldroyd-B model, expands to:
where σ is the stress tensor, T 1 is the viscous stress, T 2 is the elastic contribution to the stress, µ s is the solvent viscosity, µ p is the polymer contribution to the viscosity, and λ is the relaxation time of the viscoelastic fluid. The GLS4 formulation for steady flow of an inertialess incompressible viscoelastic fluid occupying a spatial domain Ω is: Find
where β = µs µs+µp is the viscosity ratio, S h and V h are suitably-defined interpolation and weighting function spaces for the velocity, pressure, velocity gradient and conformation and τ mom , τ cont , τ gradv and τ cons are the least-squares stabilization parameters for the momentum, continuity, interpolated traceless velocity gradient and constitutive equations, defined as
where h is the dimensionless element length. This formulation has been applied to a benchmark problem of an Oldroyd-B fluid past a circular cylinder in a channel with a width being 2 times the cylinder diameter [42] , where good agreement with the published results [78, 129] was found. The GLS4 method may be of course extended to unsteady flows; however, such extension has not been yet tested.
Design Optimization
In the context of blood pump development, considerable research on CFD-based design optimization has been made by Antaki et al. [9] , Burgreen et al. [36] , and Wu et al. [145] . The expression design optimization does not admit a universally accepted interpretation and is often confounded with the term design improvement. Design optimization denotes 24 M. Behbahani et al.
an automated iterative improvement process, in which numerical simulation is coupled with optimization techniques. This fully automated procedure stands in marked contrast to a design approach including a human expert in the iteration loop. The design optimization process is an iterative approach which has been described in Refs. [9, 36] and consists in the following steps:
• An initial shape of the device is defined,
• geometrical featues which are chosen to be variable are parametrized,
• objective functions are defined resulting in a specified performance index,
• CFD simulations are performed to characterize the flow field in terms of fluid dynamics properties,
• the objective function and its gradient are computed or estimated and analyzed with respect to their optimality,
• as long as the performance index is sub-optimal the shape parameters are modified and an additional iteration is performed.
Requirements and specific aspects for design optimization compared to design improvement are listed in Table 6 .
The design optimization strategy for blood pumps was first presented by Antaki et al. [9] , but many obstacles made its application a difficult task. According to Antaki et al. [9] , the main challenges lie in finding enhanced models for the description of the blood flow, a better description of the relationship between macroscopic and microscopic blood flow features, and adequate automated algorithms for performing shape changes in response to computed flow features.
Design optimization is a systematic methodology. For the iterations, neither heuristic knowledge nor human interaction is required and cut-and-try approaches are avoided. As the complexity of the problem rises, it becomes an increasingly time-saving and efficient method leading to an optimal solution. A particularly strong benefit of design optimization is the possibility of reaching an optimal compromise between competing design objectives by means of defining a corresponding performance index.
Wu et al. [145] presented results from CFD-based design optimization for the improvement of flow characteristics of a blood pump impeller. In this case blood was assumed to be Newtonian.
The authors' group has also successfully applied design optimization for steady [1] and unsteady [2] blood flows. These study cases include arterial grafts and are less complex than a blood pump as far as geometry is concerned; however, additional complexity was introduced by modelling blood as a shear-thinning fluid.
In our study the goal was to find a shape Ω(α) for the graft such that a given objective function J, which depends on the design variable α, is minimized. The Navier-Stokes equations (6.1-6.2) are written as a generic state equation:
c(u, p; x) = 0.
(9.1) The set of admissible shapes can be parameterized by α ∈ A ad ⊂ R n , so that the optimal design problem is given as follows: The discrete state equation is written as:
where v h = (u h , p h ). The discrete counterpart of the optimization problem can be written as:
minimize J h (α), (9.7) subject to α ∈ A ad , (9.8)
where J h (α) = J h (v h (α), x h (α), α). We use a gradient-based algorithm to solve the problem, where the gradient of J h with respect to α is given by
By computing δα the new α = α+δα can be determined and the mesh x h (α) is updated for the next iteration.
As a result of the performed analysis, it became clear that the optimal shape can show striking discrepancies in terms of fluid dynamic parameters for optimization results based on different constitutive models.
Conclusion
We have presented a review of current VAD designs, described their design requirements and outlined the important role of CFD in the context of VAD development.
We have then reviewed current understanding of the complex structure of blood, including its shear-thinning and viscoelastic behaviour, as well as tank-treading of RBCs.
We have further presented an overview of published research and current state-ofthe-art methods for the analysis of blood flow processes in VADs. Details on numerical computations performed by our research team including quantitative results for unsteady blood flow have been given for the GYRO blood pump. We have shown that CFDbased predictions of hydraulic pump performance fit well the experimental data at lower rotational speeds. It is expected that the implementation of a more accurate turbulence model will be able to achieve better agreement for higher impeller rotational speeds.
Most of the works reviewed in this paper assume blood behaves like a Newtonian fluid and reduce the 3-dimensional shear-forces acting on the RBCs by a scalar shear-stress value, which is then correlated to experimental results under steady flow. We called this method stress-based, as it assumes immediate response of RBCs to instantaneous stress values.
We have pointed out that predicting mechanical hemolysis in a blood pump is a more complex task and requires realistic hemorheological and blood damage models.
To that end, our research team has developed a tensor RBC model, derived from a model of a deforming droplet and modified to include tank-treading. By computing the morphological change of the RBCs along their pathlines through the pump, it is possible to determine hemolysis based on the RBC deformation; we called this approach a strainbased method.
We have reviewed viscoelastic modelling of blood with the Oldroyd-B model. The GLS4 method for solving steady flow of viscoelastic fluids has been reviewed, which is easy to implement as it uses equal order polynomial interpolations for all variables. Our research team is working on the development of the unsteady GLS4 method to simulate the flow through blood pumps.
The advances of design optimization in the field of VAD development have been reviewed and it was concluded that, whereas the optimization strategy has already been well described in its theory, it has not yet been applied for a complex parameterized blood pump model. Demanding implementation and computational requirements have made its application difficult. However, we have discussed the advantages of design optimization compared to a mere design improvement strategy and believe that design optimization has a powerful potential.
Future research will be directed towards further elaboration of blood and hemolysis models. The implementation of adequate turbulence models becomes important especially at high rotational speeds. The development of a thrombosis model, although not discussed in detail in this article, will be of importance in order to treat the subject of blood damage in a holistic manner. Comparative studies in blood pumps between a stress-based and a strain-based method for calculating hemolysis will serve to evaluate the predictive potential of these methods. Possibilities to further increase the performance of the GLS4 method, as specified in Ref. [42] are also being considered.
In the context of design optimization the research for realistic constitutive blood models will be of particular importance, as different results may be obtained depending on the constitutive model.
